share_log

HC Wainwright & Co. Reiterates Buy on FibroGen, Maintains $10 Price Target

Benzinga ·  Mar 18 15:45

HC Wainwright & Co. analyst Joseph Pantginis reiterates FibroGen (NASDAQ:FGEN) with a Buy and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
1
Comment Comment · Views 393

Recommended

Write a comment